Scynexis (SCYX) FCF Margin Growth (1y) (2014 - 2026)
Scynexis (SCYX) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -578,456.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -578,456.00 |
| Dec 31, 2025 | 111,271.00 |
| Sep 30, 2025 | -272,789.00 |
| Jun 30, 2025 | 92,606.00 |
| Mar 31, 2025 | -261,283.00 |
| Dec 31, 2024 | -88,059.00 |
| Sep 30, 2024 | -58,932.00 |
| Jun 30, 2024 | -153,214.00 |
| Mar 31, 2024 | 138,276.00 |
| Dec 31, 2023 | 136,303.00 |
| Sep 30, 2023 | 215,082.00 |
| Jun 30, 2023 | 146,106.00 |
| Mar 31, 2023 | 60,940.00 |
| Dec 31, 2022 | 269,818.00 |
| Sep 30, 2022 | 181,428.00 |
| Mar 31, 2022 | -227,622.00 |
| Jun 30, 2019 | -64,490.00 |
| Mar 31, 2019 | 270,000.00 |
| Dec 31, 2018 | -154,375.00 |
| Sep 30, 2018 | -151,562.00 |